coronary artery disease
myocardial revascularization
coronary angiography
fractional flow reserve

How to Cite



The aim: to study the clinical, angiographic and functional parameters, and their relation to the decision on percutaneous coronary intervention (PCI) in stable coronary artery disease (CAD) patients with intermediate coronary stenoses (ІСS) at patient and lesion levels.

Materials and methods. The cross-sectional study enrolled 123 patients (62±9 years; 73,2 % males) with stable CAD and angiographically ICS (50-90 %). Stable angina CCS class II (CCSII) was diagnosed in 70 (56,9 %) patients, class III (CCSIII) – 29 (23,6 %); 24 (19,5 %) patients were free from angina (Afree). Fractional flow reserve (FFR) was assessed in 74 (60,2 %) patients (min per patient). The hemodynamically significant lesion was considered if FFR ≤0,80 a.u. The decision to perform PCI was undertaken in 93 (76 %) patients. In addition, the functional data from 128 lesions were analyzed.

Results. The CCSIII group was characterized by less frequent previous PCI (21 % vs. 46 % in the pooled group [CCSII + Afree]; р=0,018); the predominance of cases with (max) severe [70-90 %] coronary stenosis (96 % vs. 78 % in CCSII and 54 % in Afree; ptrend<0,001); the lower (min) FFR ([median, quartiles] 0,70 (0,64-0,74) vs. 0,87 (0,81-0,90) in Afree; p˂0,002); and the decision to perform PCI in the vast majority of cases (93 % vs. 79 % in CCSII and 46 % in Afree; ptrend<0,001). The Afree/CCSII/CCSIII groups demonstrated a trend towards a decrease in frequency of cases with (max) [60-69 %] stenosis (38 %, 13 % and none, respectively; ptrend<0,001), and a tendency towards the cases with (max) [80-90 %] stenosis to be more prevalent (29 %, 39 % and 55 %, respectively; ptrend=0,051). The frequency of cases with (max) stenosis [70-79 %] was comparable in the studied groups (Afree/CCSII/CCSIII: 25 %/39 %/41 %, respectively [ptrend=0,240]). At lesion-level, all [80-90 %] lesions (n=28) appeared to be hemodynamically significant. In turn, the [60-69 %] lesions (n=24) included 5 (21 %) significant ones. Finally, the [70-79 %] lesions (n=44) included 28 (64 %) significant and 16 (36 %) non-significant ones.

Conclusions. Among the stable CAD patients with angiographically ICS, those with CCSIII were characterized by less frequent previous PCI, significant decrease in FFR and the decision to perform index PCI in the vast majority of cases. There is a need for more precise diagnosis and assessment of myocardial ischemia in patients with an intermediate pre-test obstructive CAD probability, including the cases of previously performed PCI.


Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., Hatala, R., Mahfoud, F., … ESC Scientific Document Group (2020). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European heart journal, 41(3), 407–477.

Gulati, M., Levy, P. D., Mukherjee, D., Amsterdam, E., Bhatt, D. L., Birtcher, K. K., Blankstein, R., Boyd, J., Bullock-Palmer, R. P., Conejo, T., Diercks, D. B., Gentile, F., Greenwood, J. P., Hess, E. P., Hollenberg, S. M., Jaber, W. A., Jneid, H., Joglar, J. A., Morrow, D. A., O'Connor, R. E., … Shaw, L. J. (2021). 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 144(22), e368–e454.

Neumann, F. J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J. P., Falk, V., Head, S. J., Jüni, P., Kastrati, A., Koller, A., Kristensen, S. D., Niebauer, J., Richter, D. J., Seferovic, P. M., Sibbing, D., Stefanini, G. G., Windecker, S., … ESC Scientific Document Group (2019). 2018 ESC/EACTS Guidelines on myocardial revascularization. European heart journal, 40(2), 87–165.

Writing Committee Members, Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., Fremes, S. E., Gaudino, M. F., Goldberger, Z. D., Grant, M. C., Jaswal, J. B., Kurlansky, P. A., Mehran, R., Metkus, T. S., Jr, Nnacheta, L. C., … Zwischenberger, B. A. (2022). 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 79(2), e21–e129.

Writing Committee Members, Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., Kazi, D. S., Kolte, D., Kumbhani, D. J., LoFaso, J., Mahtta, D., Mark, D. B., Minissian, M., Navar, A. M., Patel, A. R., … Williams, M. S. (2023). 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 82(9), 833–955.

Boden, W. E., Marzilli, M., Crea, F., Mancini, G. B. J., Weintraub, W. S., Taqueti, V. R., Pepine, C. J., Escaned, J., Al-Lamee, R., Gowdak, L. H. W., Berry, C., Kaski, J. C., & Chronic Myocardial Ischemic Syndromes Task Force (2023). Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week. Journal of the American College of Cardiology, 81(5), 505–514.

Boden, W. E., & Stone, P. H. (2023). Lessons Learned from the ISCHEMIA Trial for the Management of Patients with Stable Ischemic Heart Disease. Annual review of medicine, 74, 189–198.

Mavromatis, K., & Gershlick, A. (2022). The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist's Perspective. Cardiovascular drugs and therapy, 36(5), 1019–1026.

Kohsaka, S., Ejiri, K., Takagi, H., Watanabe, I., Gatate, Y., Fukushima, K., Nakano, S., & Hirai, T. (2023). Diagnostic and Therapeutic Strategies for Stable Coronary Artery Disease Following the ISCHEMIA Trial. JACC. Asia, 3(1), 15–30.

Dauerman, H. L., & Mack, M. J. (2020). International Trends in Coronary Intervention: A Bridge Over Rising Coronary Waters. Journal of the American College of Cardiology, 76(11), 1341–1344.

Kanaoka, K., Iwanaga, Y., Nakai, M., Nishioka, Y., Myojin, T., Okada, K., Noda, T., Miyamoto, Y., Saito, Y., & Imamura, T. (2023). Reduction in Planned Percutaneous Coronary Interventions After the Policy Change for Ischemia Assessment in Japan. JACC. Asia, 3(2), 312–314.

Bershtein, L., Sumin, A., Zbyshevskaya, E., Gumerova, V., Tsurtsumia, D., Kochanov, I., Andreeva, A., Piltakian, V., & Sayganov, S. (2023). Stable Coronary Artery Disease: Who Finally Benefits from Coronary Revascularization in the Modern Era? The ISCHEMIA and Interim ISCHEMIA-EXTEND Analysis. Life (Basel, Switzerland), 13(7), 1497.

Sanz Sánchez, J., Farjat Pasos, J. I., Martinez Solé, J., Hussain, B., Kumar, S., Garg, M., Chiarito, M., Teira Calderón, A., Sorolla-Romero, J. A., Echavarria Pinto, M., Shin, E. S., Diez Gil, J. L., Waksman, R., van de Hoef, T. P., & Garcia-Garcia, H. M. (2023). Fractional flow reserve use in coronary artery revascularization: A systematic review and meta-analysis. iScience, 26(8), 107245.

Escaned, J., Berry, C., De Bruyne, B., Shabbir, A., Collet, C., Lee, J. M., Appelman, Y., Barbato, E., Biscaglia, S., Buszman, P. P., Campo, G., Chieffo, A., Colleran, R., Collison, D., Davies, J., Giacoppo, D., Holm, N. R., Jeremias, A., Paradies, V., Piróth, Z., … Tarantini, G. (2023). Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 19(6), 464–481.

Nazir, M. S., Mittal, T. K., Weir-McCall, J., Nieman, K., Channon, K., & Nicol, E. D. (2020). Opportunities and challenges of implementing computed tomography fractional flow reserve into clinical practice. Heart (British Cardiac Society), 106(18), 1387–1393.

McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., Cleland, J. G. F., Coats, A. J. S., Crespo-Leiro, M. G., Farmakis, D., Gilard, M., Heymans, S., Hoes, A. W., Jaarsma, T., Jankowska, E. A., Lainscak, M., … ESC Scientific Document Group (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal, 42(36), 3599–3726.

Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J., Solomon, S., Spencer, K. T., St John Sutton, M., Stewart, W., American Society of Echocardiography's Nomenclature and Standards Committee, Task Force on Chamber Quantification, American College of Cardiology Echocardiography Committee, American Heart Association, & European Association of Echocardiography, European Society of Cardiology (2006). Recommendations for chamber quantification. European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 7(2), 79–108.

Ramanathan, S., Al Heidous, M., & Alkuwari, M. (2019). Coronary Artery Disease-Reporting and Data System (CAD-RADS): strengths and limitations. Clinical radiology, 74(6), 411–417.

Peper, J., Becker, L. M., van Kuijk, J. P., Leiner, T., & Swaans, M. J. (2021). Fractional Flow Reserve: Patient Selection and Perspectives. Vascular health and risk management, 17, 817–831.

Scoccia, A., Tomaniak, M., Neleman, T., Groenland, F. T. W., Plantes, A. C. Z. D., & Daemen, J. (2022). Angiography-Based Fractional Flow Reserve: State of the Art. Current cardiology reports, 24(6), 667–678.

Gurianov, V.G., Liakh, Y.Y., Parii, V.D., Korotkyi, O.V., Chalyi, K.O., & Tsekhmister, Y.V. (2018). Posibnyk z biostatystyky. Analiz rezultativ medychnykh doslidzhen u paketi EZR (R-statistics) [Handbook of biostatistics. Analysis of medical research results in the EZR package (R-statistics)]. Kyiv: Vistka. (In Ukrainian).

Liu, Y., Chen, Y., Chang, Z., Han, Y., Tang, S., Zhao, Y., Fu, J., Liu, Y., & Fan, Z. (2023). Appropriateness of Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis. Journal of cardiovascular development and disease, 10(3), 93.

Groenhoff, L., De Zan, G., Costantini, P., Siani, A., Ostillio, E., Carriero, S., Muscogiuri, G., Bergamaschi, L., Patti, G., Pizzi, C., Sironi, S., Pavon, A. G., Carriero, A., & Guglielmo, M. (2023). The Non-Invasive Diagnosis of Chronic Coronary Syndrome: A Focus on Stress Computed Tomography Perfusion and Stress Cardiac Magnetic Resonance. Journal of clinical medicine, 12(11), 3793.

Safian R. D. (2023). Computed Tomography-Derived Physiology Assessment: State-of-the-Art Review. Interventional cardiology clinics, 12(1), 95–117.

Verdoia, M., & Rognoni, A. (2023). Coronary Physiology: Modern Concepts for the Guidance of Percutaneous Coronary Interventions and Medical Therapy. Journal of clinical medicine, 12(6), 2274.

Sharifkazemi, M., Hooshanginezhad, Z., Zoroufian, A., & Shamsa, K. (2023). Is it the Time to Move Towards Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve Guided Percutaneous Coronary Intervention? The Pros and Cons. Current cardiology reviews, 19(4), e190123212887.

Dobrić, M., Furtula, M., Tešić, M., Timčić, S., Borzanović, D., Lazarević, N., Lipovac, M., Farkić, M., Ilić, I., Boljević, D., Rakočević, J., Aleksandrić, S., Juričić, S., Ostojić, M., & Bojić, M. (2023). Current status and future perspectives of fractional flow reserve derived from invasive coronary angiography. Frontiers in cardiovascular medicine, 10, 1181803.

Peper, J., Bots, M. L., Leiner, T., & Swaans, M. J. (2023). Non-invasive Angiographic-based Fractional Flow Reserve: Technical Development, Clinical Implications, and Future Perspectives. Current medical science, 43(3), 423–433.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.